Skip to content
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Pediatric Cardiology

Treatment and Management: Protecting the Heart and Skin

At a Glance

Carvajal syndrome is managed with lifelong specialist care: medicines support weakened heart function, an ICD may protect against life-threatening rhythms, intense exercise should be avoided, and thickened palm-and-sole skin needs guided treatment.

Managing Carvajal syndrome requires a proactive, dual-focused approach. Because the condition affects both the heart’s structure and its electrical system, the goal of treatment is to support the heart muscle, prevent dangerous rhythms, and manage the skin and hair features that appear early in life [1][2].

Safety Warning: Do not change medications, stop prescribed treatments, or alter exercise habits without explicit instructions from your cardiology team.

Managing Heart Function

When the heart’s pumping chamber (the left ventricle) begins to weaken or enlarge, doctors use a group of medications known as guideline-directed medical therapy (GDMT). These are designed to take the workload off the heart and help it pump more efficiently [3][4].

  • ACE Inhibitors or ARBs: These medications help relax blood vessels, lowering blood pressure and making it easier for the heart to pump blood to the body [5][4].
  • Beta-blockers: These slow the heart rate and protect the heart muscle from the effects of stress hormones like adrenaline, which can be harmful to a weakened heart [3][4].
  • Diuretics: Often called “water pills,” these help the body get rid of extra fluid and salt, reducing swelling and making it easier for your child to breathe [3][4].
  • Mineralocorticoid Receptor Antagonists (MRAs): These may be added to further protect the heart from scarring (fibrosis) [5][4].

Protecting the Heart Rhythm

Because the “molecular glue” (desmoplakin) is weak, the heart’s electrical signals can become disrupted, leading to irregular heartbeats (arrhythmias) [6][7]. To treat life-threatening rhythms, patients with Carvajal syndrome may be considered for an Implantable Cardioverter Defibrillator (ICD) [8][9].

An ICD is a small device placed under the skin that constantly monitors the heart rhythm. If it detects a life-threatening, rapid rhythm, it can deliver an electrical shock to reset the heart to a normal beat [8]. In children, the decision to place an ICD is highly individualized, considering potential complications such as infection, lead failure as the child grows, and inappropriate shocks. Doctors look for “risk markers” such as:

  • Fainting episodes (syncope) [10].
  • Significant scarring patterns on a cardiac MRI [6].
  • Episodes of “racing heart” (nonsustained ventricular tachycardia) detected on a wearable monitor [9][11].
  • A significantly weakened pumping ability (low ejection fraction) [8][11].

The Critical Role of Exercise Restriction

There is strong medical consensus based on current guidelines that patients with Carvajal syndrome should avoid competitive, high-intensity, and endurance sports [12][13]. This is not just a general precaution; it is based on the biology of the disease.

When a person exercises intensely, the heart must stretch and pump much harder. In a healthy heart, the “molecular glue” holds the cells together during this stress. In Carvajal syndrome, the glue is defective. High-intensity exertion is associated with pulling the heart cells apart, triggering inflammation, cell death, and the formation of scar tissue [14][15]. This process directly accelerates heart failure and increases the risk of dangerous arrhythmias [13][16]. However, low-to-moderate intensity activity, such as walking or gentle play, is often encouraged under medical supervision [12].

Caring for the Skin and Hair

While the heart is the priority, managing the skin thickening (palmoplantar keratoderma) is essential for your child’s comfort and mobility.

  • Moisturization and Fissure Care: Emphasize daily moisturization and clean care for any painful cracks to prevent infection.
  • Keratolytics: These are topical creams containing ingredients like urea, salicylic acid, or lactic acid that help soften and thin the thickened skin [17][18]. Pediatric Safety Note: Salicylic acid can be absorbed systemically in children when used over large areas. Use strictly under a dermatologist’s guidance.
  • Retinoids: In some cases, oral or topical retinoids (vitamin A derivatives) may be used to slow the overgrowth of skin cells [17][19]. Pediatric Safety Note: Oral retinoids are teratogenic and require specialist prescribing and monitoring. Do not self-start.
  • Footwear and Comfort: Using specialized, well-cushioned footwear can reduce the friction that triggers skin thickening and prevent painful cracks (fissures) [20][21]. Regular mechanical debridement (gently filing the skin) by a specialist may also be recommended, but aggressive filing can cause injury [20].

Because this condition is progressive, the most effective “treatment” is consistent, lifelong monitoring by a team that includes pediatric cardiologists, electrophysiologists, and dermatologists [1][2].

Common questions in this guide

What medicines may be used to treat Carvajal syndrome?
If the left ventricle is weakened or enlarged, clinicians may use heart-failure medicines such as ACE inhibitors or ARBs, beta-blockers, diuretics, and mineralocorticoid receptor antagonists. The cardiology team chooses and adjusts medicines based on the child’s heart function and symptoms, so caregivers should not change doses without instructions.
When might a child with Carvajal syndrome need an ICD?
An implantable cardioverter-defibrillator may be considered when there is a meaningful risk of life-threatening ventricular rhythms, but it is not automatically needed for every child. Doctors weigh factors such as fainting, scarring on cardiac MRI, nonsustained ventricular tachycardia, and a low ejection fraction, along with the child’s age, size, and device-related risks.
Why are intense sports restricted in Carvajal syndrome?
Competitive, high-intensity, and endurance exercise can place extra mechanical stress on a heart affected by defective desmoplakin, potentially worsening cell injury and scarring and increasing the risk of heart failure or dangerous arrhythmias. Walking and gentle play may be allowed when the medical team considers them safe.
What activities are usually safe for a child with Carvajal syndrome?
The cardiology team should provide a written, individualized activity plan. Low- to moderate-intensity activities such as walking or gentle play are often encouraged under medical supervision, while competitive, high-intensity, and endurance sports should generally be avoided.
How can thickened skin and painful cracks be treated?
Daily moisturization, careful fissure care, and cushioned footwear can improve comfort and reduce friction. Dermatologists may recommend keratolytics such as urea, salicylic acid, or lactic acid, or retinoids in selected cases; treatments over large areas and oral retinoids require specialist guidance, especially in children.
What kind of long-term follow-up does Carvajal syndrome require?
Because Carvajal syndrome can progress, children need lifelong monitoring by pediatric cardiologists, electrophysiologists, and dermatologists. Follow-up may track heart pumping function, rhythm abnormalities, exercise safety, and skin symptoms, and new fatigue, dizziness, fainting, swelling, or breathing problems should be reported to the care team.

Get notified when new evidence is published on Carvajal syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (21)
  1. 1

    Carvajal Syndrome- A Variant of Naxos Disease: A Case Report.

    Mandal KD, Shrestha PN, Ghimire A, et al.

    JNMA; journal of the Nepal Medical Association 2022; (60(246)):187-191 doi:10.31729/jnma.7102.

    PMID: 35210635
  2. 2

    A case of Carvajal syndrome presenting with dilated cardiomyopathy.

    Arıcı S, Akalın F, Geckinli BB

    Cardiology in the young 2024; (34(5)):1131-1133 doi:10.1017/S1047951124000222.

    PMID: 38433550
  3. 3

    Noncompaction and dilated cardiomyopathy in carvajal syndrome.

    Tosun D, Akçay N, Bingöl İ, Akbulut DG

    Cardiology in the young 2025; (35(5)):1073-1075 doi:10.1017/S1047951125001532.

    PMID: 40260958
  4. 4

    Heart Failure With Reduced Ejection Fraction: A Review.

    Murphy SP, Ibrahim NE, Januzzi JL

    JAMA 2020; (324(5)):488-504 doi:10.1001/jama.2020.10262.

    PMID: 32749493
  5. 5

    A Case of Premature Ventricular Contraction-Induced Cardiomyopathy.

    Mazar M, Hingorany S

    Cureus 2025; (17(8)):e91034 doi:10.7759/cureus.91034.

    PMID: 41018405
  6. 6

    Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.

    Smith ED, Lakdawala NK, Papoutsidakis N, et al.

    Circulation 2020; (141(23)):1872-1884 doi:10.1161/CIRCULATIONAHA.119.044934.

    PMID: 32372669
  7. 7

    PANoptosis is a prominent feature of desmoplakin cardiomyopathy.

    Olcum M, Rouhi L, Fan S, et al.

    The journal of cardiovascular aging 2023; (3(1)) doi:10.20517/jca.2022.34.

    PMID: 36818425
  8. 8

    Desmoplakin Cardiomyopathy in Pediatric Patients: A Distinct, Underrecognized Cohort of Arrhythmogenic Cardiomyopathy.

    Choi NH, Cherny S, Berul CI, et al.

    Circulation. Arrhythmia and electrophysiology 2024; (17(11)):e013114 doi:10.1161/CIRCEP.124.013114.

    PMID: 39523938
  9. 9

    Clinical features and outcomes in carriers of pathogenic desmoplakin variants.

    Gasperetti A, Carrick RT, Protonotarios A, et al.

    European heart journal 2025; (46(4)):362-376 doi:10.1093/eurheartj/ehae571.

    PMID: 39288222
  10. 10

    A truncating variant altering the extreme C-terminal region of desmoplakin (DSP) suggests the crucial functional role of the region: a case report study.

    Pantou MP, Gourzi P, Vlagkouli V, et al.

    BMC medical genomics 2023; (16(1)):95 doi:10.1186/s12920-023-01527-6.

    PMID: 37143080
  11. 11

    Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy.

    Smith E, Gasperetti A, Carrick RT, et al.

    medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.06.16.25329734.

    PMID: 40666337
  12. 12

    Role of Exercise as a Modulating Factor in Arrhythmogenic Cardiomyopathy.

    Zorzi A, Cipriani A, Bariani R, et al.

    Current cardiology reports 2021; (23(6)):57 doi:10.1007/s11886-021-01489-0.

    PMID: 33961139
  13. 13

    Harmful Effects of Exercise Intensity and Exercise Duration in Patients With Arrhythmogenic Cardiomyopathy.

    Lie ØH, Dejgaard LA, Saberniak J, et al.

    JACC. Clinical electrophysiology 2018; (4(6)):744-753 doi:10.1016/j.jacep.2018.01.010.

    PMID: 29929667
  14. 14

    Desmoplakin Cardiomyopathy: Gene Dose-Dependent Myocardial Remodeling, Arrhythmias, and Premature Death.

    Guazzo A, Perumal Vanaja I, Di Bona A, et al.

    JACC. Clinical electrophysiology 2026; (12(4)):747-764 doi:10.1016/j.jacep.2025.10.031.

    PMID: 41411472
  15. 15

    Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy.

    Chelko SP, Keceli G, Carpi A, et al.

    Science translational medicine 2021; (13(581)) doi:10.1126/scitranslmed.abf0891.

    PMID: 33597260
  16. 16

    Prediction of Life-Threatening Ventricular Arrhythmia in Patients With Arrhythmogenic Cardiomyopathy: A Primary Prevention Cohort Study.

    Lie ØH, Rootwelt-Norberg C, Dejgaard LA, et al.

    JACC. Cardiovascular imaging 2018; (11(10)):1377-1386 doi:10.1016/j.jcmg.2018.05.017.

    PMID: 30031702
  17. 17

    Treatment of hereditary palmoplantar keratoderma: a review by analysis of the literature.

    Bodemer C, Steijlen P, Mazereeuw-Hautier J, O'Toole EA

    The British journal of dermatology 2021; (184(3)):393-400 doi:10.1111/bjd.19144.

    PMID: 32307694
  18. 18

    Sporadic Diffuse Palmoplantar Keratoderma in a Pediatric Patient With Early Onset: A Case Report.

    Premkumar L, Preethi P S, Swaminathan A, Sundaram M

    Cureus 2025; (17(12)):e100318 doi:10.7759/cureus.100318.

    PMID: 41613660
  19. 19

    A Mal De Meleda patient with severe flexion contractures of hands and feet: A case report in West China.

    Pan Y, Zhao H, Chen A, Huang X

    Medicine 2017; (96(36)):e7972 doi:10.1097/MD.0000000000007972.

    PMID: 28885351
  20. 20

    Pachyonychia Congenita: Clinical Features and Future Treatments.

    McCarthy RL, de Brito M, O'Toole E

    The Keio journal of medicine 2025; (74(1)):52-60 doi:10.2302/kjm.2023-0012-IR.

    PMID: 37766547
  21. 21

    Pain mechanisms in hereditary palmoplantar keratodermas.

    Weinberg RL, Coulombe PA, Polydefkis M, Caterina MJ

    The British journal of dermatology 2020; (182(3)):543-551 doi:10.1111/bjd.17880.

    PMID: 30883689

This page explains Carvajal syndrome treatment and daily management for informational purposes only and does not constitute medical advice. A pediatric cardiology, electrophysiology, and dermatology team should guide medications, exercise, ICD decisions, and skin treatments for your child.